Increased Myostatin Activity and Decreased Myocyte Proliferation in Chronic Alcoholic Cardiomyopathy

Alcoholism: Clinical and Experimental Research

Volumn 35, Issue 7, 2011, Pages 1220-1229

  Fernández Solà, Joaquim ^a,b   Lluis, Meritxell ^a   Sacanella, Emilio ^a,b   Estruch, Ramón ^a,b   Antúnez, Emilia ^a   Urbano Márquez, Alvaro ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Alcohol; Apoptosis; Myocardium; Myocyte Proliferation; Myostatin

Indexed keywords

ALCOHOL; MYOSTATIN;

ALCOHOLIC CARDIOMYOPATHY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HEART MUSCLE CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; ALCOHOLISM; CARDIOMYOPATHY, ALCOHOLIC; CELL PROLIFERATION; CHRONIC DISEASE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIUM; MYOCYTES, CARDIAC; MYOSTATIN; UP-REGULATION;

EID: 79959226283     PISSN: 01456008     EISSN: 15300277     Source Type: Journal    
DOI: 10.1111/j.1530-0277.2011.01456.x     Document Type: Article

References (53)

1. Altura BM, Gebrewold A (1998) Pyrrolidine dithiocarbamate attenuates alcohol-induced leykocyte-endothelial cell interaction and cerebral vascular damage in rats: possible role of activation of transcription factor NF-kappa-β in alcohol brain pathology. Alcohol 26:25-28.
2. Anversa P, Nadal-Ginard B (2002) Myocyte renewal and ventricular remodeling. Nature 415:240-243.
3. Beltrami A, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Nadal-Ginard B, Anversa A (2003) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114:763-776.
4. Beltrami A, Urbanek K, Kajstura J, Yan S, Finato N, Bussani R, Nadal-Ginard B, Silvestri F, Leri A, Beltrami C, Anversa P (2001) Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 344:1750-1757.
5. Bergmann O, Bharwaj RD, Bernard S, Zdunek Sm Barnabé-Heider F, Walsh S, Zupicich J, Alkass K, Bucholz BA, Druid H, Jovinge S, Frisén J (2009) Evidence for cardiomyocyte renewal in humans. Science 324:98-102.
6. Buja LM, Vela D (2008) Cardiomyocyte death and renewal in the normal and diseased heart. Cardiovasc Pathol 17:349-374.
7. Casey CA, Nanji A, Cederbaum AI, Adachi M, Takahashi T (2001) Alcoholic liver disease and apoptosis. Alcohol Clin Exp Res 25:49S-53S.
8. Fatjó F, Fernández-Solà J, Lluís M, Elena M, Badia E, Sacanella E, Estruch R, Nicolás JM (2005) Myocardial antioxidant status in chronic alcoholism. Alcohol Clin Exp Res 29:864-870.
9. Fernández-Solà J, Estruch R, Grau JM, Pare JC, Rubin E, Urbano-Márquez A (1994) The relation of alcoholic myopathy to cardiomyopathy. Ann Intern Med 120:529-536.
10. Fernández-Solà J, Fatjó F, Sacanella E, Estruch R, Bosch X, Urbano-Márquez A, Nicolas JM (2006) Evidence of apoptosis in alcoholic cardiomyopathy. Hum Pathol 37:1100-1110.
11. Fernández-Solà J, Preedy VR, Lang C, González Remiers E, Arno M, Lin JCI, Wiseman H, Zhou S, Emery PW, Nakarama T, Hashimoto K, Hirano M, Santolaria-Fernandez F, González-Hernández T, Fatjó J, Sacanella E, Estruch R, Nicolas JM, Urbano-Márquez A (2007) Molecular events in alcohol-induced muscle disease. Alcohol Clin Exp Res 31(12):1-10.
12. Fernández-Solà J, Sacanella E, Estruch R, Lluis M, Antúnez E, Urbano-Márquez A (2008) Factors influencing myocyte death and regeneration in alcoholic cardiomyopathy. Alcohol Clin Exp Res (Suppl) 38:308A.
13. Goldman L, Hashimoto B, Cook EF, Loscalzo A (1981) Comparative reproducibility and validity of assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation 64:1227-1234.
14. Gottdiener JS, Berdnarz J, Devereux R, Gardin J, Klein A, Manning WJ, Morehead A, Kitzman D, Oh J, Quinones M, Schiller NB, Stein JH, Weissman NJ (2004) American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr 17:1086-1119.
15. Guillo P, Mansourati J, Maheu B, Etienne Y, Provost K, Simon O, Blanc JJ (1997) Long-term prognosis in patients with alcoholic cardiomyopathy and severe heart failure after total abstinence. Am J Cardiol 79:1276-1278.
16. Gürtl B, Kratky D, Guelly C, Zhang L, Gorkiewicz G, Das SK, Tamilarasan KP, Hoefler G (2009) Apoptosis and fibrosis are early features of heart failure in an animal model of metabolic cardiomyopathy. Int J Exp Pathol 90:338-346.
17. Hajnóczky G, Buzas CJ, Pacher P, Hoek JB, Rubin E (2005) Alcohol and mitochondria in cardiac apoptosis: mechanisms and visualization. Alcohol Clin Exp Res 29:693-701.
18. Hill JA, Olson E (2008) Cardiac plasticity. N Engl J Med 358:1370-1380.
19. Hoek JB, Pasimoro JG (2002) Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol Clin Exp Res 27:63-38.
20. Jänkälä A, Eriksson P, Eklund K, Härkönen M, Mäki T (2002) Combined calcium carbimide and ethanol treatment induces high blood acetaldehyde levels, myocardial apoptosis and alters expression of apoptosis-regulating genes in rat. Alcohol Alcohol 37:222-228.
21. Joulia-Ekaza D, Cabello G (2006) Myostatin regulation of muscle development: molecular basis, natural mutations, physiopathological aspects. Exp Cell Res 312:2401-2414.
22. Kajstura J, Leri A, Finato N, Di Loreto C, Beltrami CA, Anversa P (1998) Myocyte proliferation in end-stage cardiac failure in humans. Proc Natl Acad Sci USA 95:8801-8805.
23. Kanoh M, Takemura G, Misao J, Hayakawa Y, Aoyama T, Nishigaki K, Noda T, Fujiwara T, Fukuda K, Minatoguchi S, Fujiwara H (1999) Significance of myocytes with positive DNA in situ nick end-labelling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair. Circulation 99:2757-2764.
24. Lang CH, Frost RA, Svanberg E, Vary TC (2004) IGF-I/IGFBP-3 ameliorates alterations in protein synthesis, eIF4E availability, and myostatin in alcohol-fed rats. Am J Physiol Endocrinol Metab 286:E916-E926.
25. Laonigro I, Correale M, Di BM, Altomare E (2009) Alcohol abuse and heart failure. Eur J Heart Fail 11:453-462.
26. McKoy G, Bicknell KA, Patel K, Brooks G (2007) Developmental expression of myostatin in cardiomyocytes and its effect on foetal and neonatal rat cardiomyocyte proliferation. Cardiovasc Res 74:304-312.
27. Molina P, McClain P, Valla D, Guidot D, Diehl A, Lang C, Neuman M (2002) Molecular pathology and clinical aspects of alcohol-induced tissue injury. Alcohol Clin Exp Res 26:120-128.
28. Moushmoush B, Ali-Mansour P (1991) Alcohol and the heart: the long-term effects of alcohol on the cardiovascular system. Arch Intern Med 151:36-42.
29. Nadal-Ginard B, Kajstura J, Anversa P, Leri A (2003) A matter of life and death: cardiac myocyte apoptosis and regeneration. J Clin Invest 111:1457-1459.
30. Narula J, Haider N, Virmani R (1996) Apoptosis in myocytes in end-stage heart failure. N Engl J Med 335:1182-1189.
31. Neuss M, Crow MT, Chelsey A, Lakatta EG (2001) Apoptosis in cardiac disease: what is it-how does it occur? Cardiovasc Drugs Ther 15:509-525.
32. Nicolás JM, Antúnez E, Thomas AP, Fernández-Solà J, Tobías E, Estruch R, Urbano-Márquez A (1998) Ethanol acutely decreases calcium transients in cultured human myotubes. Alcohol Clin Exp Res 22:1086-1092.
33. Nicolás JM, Fernández-Solà J, Estruch R, Paré JC, Sacanella E, Urbano Márquez A, Rubin E (2002) The effect of controlled drinking in alcoholic cardiomyopathy. Ann Intern Med 136:192-200.
34. Paul M (2001) Apoptosis in cardiac disease: from basics to clinics-an editorial commentary. Symposium: Programmed Cell Death-Clinical Reality and Therapeutic Strategies. Cardiovasc Drugs Ther 15:553-554.
35. Preedy VR, Patel VB, Why HJF, Corbett JM, Dunn MJ, Richarson PJ (1996) Alcohol and heart: biochemical alterations. Cardiovasc Res 31:139-147.
36. Rajiyah G, Agarwal R, Avendano G, Lyons M, Soni B, Regan TJ (1996) Influence of nicotine on myocardial stiffness and fibrosis during chronic ethanol use. Alcohol Clin Exp Res 20:985-989.
37. Regula K, Rzeszutek J, Baetz D, Seneviratne C, Kirshenbaum A (2004) Therapeutic opportunities for cell cycle re-entry and cardiac regeneration. Card Res 64:395-401.
38. Ren J, World LE (2008) Mechanisms of alcohol heart disease. Ther Adv Cardiovasc Dis 2:497-506.
39. Sandri M, Carraro U, Podhorska-Okolow M (1995) Apoptosis DNA damage and ubiquitin expression in normal and mdx muscle fibers after exercise. FEBS Lett 373:291-295.
40. Saraste A, Pulkki K, Kallajoki M, Heikkilä P, Laine P, Mattila S, Nieminen MS, Parvinen M, Voipio-Pulkki LM (1999) Cardiomyocyte apoptosis and progression of heart failure to transplantation. Eur J Clin Invest 29:380-386.
41. Sharma M, Kambadur R, Matthews KG, Somers WG, Devlin GP, Conaglen JV, Fowke PJ (1999) Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct. J Cell Physiol 180:1-9.
42. Shyu KG, Ko WH, Yang WS, Wang BW, Kuan P (2005) Insulin-like growth factor-1 mediates stretch-induced upregulation of myostatin expression in neonatal rat cardiomyocytes. Cardiovasc Res 68:405-414.
43. Shyu KG, Lu MJ, Wang BW, Sun HY, Chang H (2006) Myostatin expression in ventricular myocardium in a rat model of volume-overload heart failure. European J Clin Investig 36:713-719.
44. Sobel LC, Maisto SA, Sobell MB, Cooper AM (1979) Reliability of alcohol abusers' self-reports of drinking behaviour. Behav Res Ther 17:157-160.
45. Spies CD, Sander M, Stangl K, Fernández-Solà J, Preedy VR, Rubin E, Andreasson S, Hanna EZ, Kox WJ (2001) Effects of alcohol on the heart. Curr Opin Crit Care 7:337-343.
46. Urbano-Márquez A, Estruch R, Navarro-López F, Grau JM, Mont L, Rubin E (1989) The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med 320:409-411.
47. Urbano-Márquez A, Fernández-Solà J (2004) The effect of alcohol on cardiac and skeletal muscle. Muscle Nerve 30:689-707.
48. Von Harsdorf R, Poole-Wilson P, Dietz R (2004) Regenerative capacity of the myocardium: implications for treatment of heart failure. Lancet 363:1306-1313.
49. Wagner K, Liu X, Chang X, Allen R (2005) Muscle regeneration in the prolonged abscence of myostatin. PNAS 102:2519-2524.
50. Webster K, Bishopric N (2003) Apoptosis inhibitors for heart disease. Circulation 108(24):2954-2956.
51. Williams RS (1999) Apoptosis and heart failure. N Engl J Med 96:1580-1585.
52. Yang W, Zhang Y, Ma G, Chen Y, Zhu D (2005) Identification of gene expression modifications in myostatin-stimulated myoblasts. Biochem Biophys Res Commun 326:660-666.
53. Zakhari S (1991) Vulnerability to cardiac disease. Recent Dev Alcohol 9:225-260.